Announcements Trials

Browse Landscape

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 576 Neoplasms 470 Lung Neoplasms 303 Colorectal Neoplasms 297 Carcinoma, Non-Small-Cell Lung 219 Stomach Neoplasms 215 Carcinoma, Hepatocellular 204 Prostatic Neoplasms 183 Pancreatic Neoplasms 156 Ovarian Neoplasms 143 Uterine Cervical Neoplasms 128 Colonic Neoplasms 122 Rectal Neoplasms 114 Urinary Bladder Neoplasms 100 Neoplasm Metastasis 95 Esophageal Neoplasms 90 Endometrial Neoplasms 86 Head and Neck Neoplasms 85 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Leukemia, Myeloid, Acute 79 Brain Neoplasms 69 Recurrence 68 Melanoma 66 Disease 65 Liver Neoplasms 60 Multiple Myeloma 59 Lymphoma 59 Glioma 58 Squamous Cell Carcinoma of Head and Neck 54 Polycystic Ovary Syndrome 53

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observational × HER2-positive Metastatic Breast Cancer × Clear all

NCT05188495 2022-01-12

HELP

Peking University Cancer Hospital & Institute

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡